CLINICAL_TRIALS
trial_result
· 2024-03-06
Clinical Trial Update: Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients [Phase 4]
Summary
Phase 4 clinical trial update evaluating vasopressin as a primary vasoconstrictor in critically ill patients with circulatory shock.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Thessaly | Conditions: Circulatory Shock | Phase 4 | Status: UNKNOWN